Vaginal Cancer
78
20
22
44
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.6%
2 terminated out of 78 trials
95.7%
+9.1% vs benchmark
14%
11 trials in Phase 3/4
23%
10 of 44 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 44 completed trials
Clinical Trials (78)
DESTINY-PANTUMOUR04
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
Vagina-View Safety and Imaging Feasibility
ASk Questions in GYnecologic Oncology (ASQ-GYO)
Integrated Cancer Repository for Cancer Research
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies
Assessment of Sexual Quality of Life Following Local Treatment (Radiotherapy With or Without Surgery) in Patients With HPV-positive Pelvic Cancer: a Descriptive Longitudinal Study
3D Printed Custom Applicators for HDR BT (DISCO)
Image-Guided Gynecologic Brachytherapy
Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
Enhanced Assistance During Radiotherapy for Unmet Essential Needs
Radiochemotherapy and Interventional Radiotherapy in Vaginal Cancer
Primary Organoid Models and Combined Nucleic Acids Therapeutics for Anti-HPV Treatments
NYSCF Scientific Discovery Biobank
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Study of a Rapid Triadic Communication Intention Elicitation Intervention to Improve Supportive Oncology Care Delivery
Long-term Follow-up of Bivalent Human Papillomavirus (HPV) Vaccine Study in Women